HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Traditional Chinese Medicine

677.624

+5.9640.89%

Number of Gainers:5

Number of Losers:3

Number of Flat:3

PE:- -

High:689.041

Open:670.599

Low:668.258

Close:671.660

Loading ...

Zhongzhi Pharmaceutical Holdings (HKG:3737) Has Announced That It Will Be Increasing Its Dividend To CN¥0.05

Simply Wall St.

Baiyunshan Pharmaceutical's Unit Amends Production License

MT Newswires Live

Hong Kong Stocks Reverse Early Losses to End Higher; Pharma Stocks Slide

MT Newswires Live

China Traditional Chinese Medicine Controlling Shareholder Boosts Stake

MT Newswires Live

Hong Kong Pharma Stocks Decline as Trump Threatens Tariffs on Imported Drugs

MT Newswires Live

BRIEF-Modern Chinese Medicine Says To Allot And Issue Aggregate Of 120 Mln Subscription Shares

Modern Chinese Medicine Group Co - to Allot and Issue Aggregate of 120Mln Subscription Shares at HK$0.27 per Share

THOMSON REUTERS

BRIEF-China Traditional Chinese Medicine Says Controlling Shareholder Acquired 50.4 Million Shares Of Co

China Traditional Chinese Medicine - Controlling Shareholder Acquired 50.4 Mln Shares of Co at an Average Price of HK$1.86 per Share

THOMSON REUTERS

Luye Pharma Gets Macao Approval for Antidepressant

MT Newswires Live

Consun Pharmaceutical - Young Yuk Chuen David Appointed as an Executive Director

THOMSON REUTERS

BRIEF-Luye Pharma Says Antidepressant Ruoxinlin Approved For Marketing In Macao

Luye Pharma - Class 1 Innovative Antidepressant Ruoxinlin Approved for Marketing in Macao

THOMSON REUTERS

Calculating The Intrinsic Value Of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:874)

Simply Wall St.

JBM (Healthcare) Unit Buys 90% Stake in Medicine Maker

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK1606/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1606\",,,,,undefined,":{"symbol":"BK1606","market":"HK","secType":"PLATE","nameCN":"Traditional Chinese Medicine","latestPrice":677.6241,"timestamp":1744877287881,"preClose":671.66003,"halted":0,"volume":176137590,"delay":0,"changeRate":0.00888,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":5.96405,"latestTime":"04-17 16:00:00","open":670.5986,"high":689.04083,"low":668.2575,"amount":364419463,"amplitude":0.030943,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745285400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1744853400000,1744862400000],[1744866000000,1744876800000]],"pbRate":0.871716,"peRate":13.290491,"turnoverRate":0.011637,"increases":5,"decrements":4,"flats":2,"marketCap":74043656688,"floatMarketCap":47711364592},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1606\",,,,,undefined,":{"symbol":"BK1606","high":689.04083,"amplitude":0.030943,"preClose":671.66003,"low":668.2575,"pbRate":"0.871716","latestPrice":677.6241,"volume":176137590,"delay":0,"open":670.5986,"prevYearClose":739.0471,"prevWeekClose":677.624,"prevMonthClose":689.055,"prevQuarterClose":689.055,"fiveDayClose":664.621,"twentyDayClose":741.616,"sixtyDayClose":658.957,"secType":"PLATE","market":"HK","turnoverRate":0.011637,"peRate":13.290491,"marketCap":74043656688,"floatMarketCap":47711364592,"timestamp":1744877287881,"nameCN":"Traditional Chinese Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1606\",,,,undefined,":{"bkCode":"BK1606","up":5,"down":3,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1606\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526657132","title":"Zhongzhi Pharmaceutical Holdings (HKG:3737) Has Announced That It Will Be Increasing Its Dividend To CN¥0.05","url":"https://stock-news.laohu8.com/highlight/detail?id=2526657132","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526657132?lang=en_us&edition=fundamental","pubTime":"2025-04-11 06:15","pubTimestamp":1744323321,"startTime":"0","endTime":"0","summary":"The board of Zhongzhi Pharmaceutical Holdings Limited ( HKG:3737 ) has announced that it will be paying its dividend of...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice1-main-header/1585186890345","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice1-main-header/1585186890345"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3737/zhongzhi-pharmaceutical-holdings-shares/news/zhongzhi-pharmaceutical-holdings-hkg3737-has-announced-that","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1606","03737","CN","BK1191","CAGR","BK4159"],"gpt_icon":0},{"id":"2526553552","title":"Baiyunshan Pharmaceutical's Unit Amends Production License","url":"https://stock-news.laohu8.com/highlight/detail?id=2526553552","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526553552?lang=en_us&edition=fundamental","pubTime":"2025-04-10 18:08","pubTimestamp":1744279688,"startTime":"0","endTime":"0","summary":"Guangzhou Baiyunshan Pharmaceutical's  unit, Guangzhou Baiyunshan Mingxing Pharmaceutical, amended its production license after receiving approval from the Guangdong Provincial Medical Products Administration.The Chinese pharmaceutical company said it will add new production scopes and production lines, as well as confirm its compliance with good manufacturing practices or GMP, in the amended license.The new production address added to the license is No. 99, Jianxu 3rd Road, Baiyun District, Guangzhou, and the new production workshop is Manufacturing Department 8. The production line, which passed GMP standards, produces lyophilized powder injections for anti-tumor drugs.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["600332","BK0070","BK1521","BK1606","BK0188","BK0028","BK1197","BK0183","BK0097","BK0096","BK0175","BK1191","BK1515","BK0196","00874","BK0239","BK0012"],"gpt_icon":0},{"id":"2526378903","title":"Hong Kong Stocks Reverse Early Losses to End Higher; Pharma Stocks Slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2526378903","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526378903?lang=en_us&edition=fundamental","pubTime":"2025-04-09 17:18","pubTimestamp":1744190288,"startTime":"0","endTime":"0","summary":"Hong Kong stocks reversed earlier losses to finish moderately higher on Wednesday, as sentiment improved on hopes that China will roll out fresh measures to shield the economy from US tariffs.The Hang","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1588","HK0000320223.HKD","HSI","LU1969619763.USD","02186","02833","09688","BK1576","LU0307460666.USD","BK1161","HK0000306701.USD","BK1500","LU2328871848.SGD","BK1574","HHImain","BK1191","513600","HK0000320264.USD","LU0588546209.SGD","HK0000306685.HKD","06955","BK1141","LU2488822045.USD","BK1606","06160","MCHmain","09966","01548","BK1583"],"gpt_icon":0},{"id":"2526773338","title":"China Traditional Chinese Medicine Controlling Shareholder Boosts Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2526773338","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526773338?lang=en_us&edition=fundamental","pubTime":"2025-04-09 16:07","pubTimestamp":1744186052,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine  controlling shareholder China National Pharmaceutical Group or CNPGC purchased 50,350,000 shares at an average of HK$1.86 apiece, according to a Tuesday filing with the Hong Kong bourse.CNPGC holds 33.46% of China Traditional Chinese Medicine's entire stake as enlarged by the offering.Shares rose 1% during Wednesday's afternoon trading.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","BK1606","00570","BK1515"],"gpt_icon":0},{"id":"2526996382","title":"Hong Kong Pharma Stocks Decline as Trump Threatens Tariffs on Imported Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2526996382","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526996382?lang=en_us&edition=fundamental","pubTime":"2025-04-09 15:25","pubTimestamp":1744183543,"startTime":"0","endTime":"0","summary":"Hong Kong pharmaceutical stocks fell on Wednesday after US President Donald Trump said his administration would soon implement \"a major tariff on pharmaceuticals\" from foreign nations.Trump made the remarks at a Republican event, suggesting the move will force drug companies to relocate their operations to the US, according to a USA Today report.While initially sparing pharmaceuticals from recent tariffs, Trump has indicated for months that the imported drug industry is a future target, the report said.The news sent shares of Hong Kong-listed drugmakers falling on Wednesday afternoon.Alphamab Oncology  led the decliners with an almost 6% fall, followed by Boan Biotech  with a 5% drop. Luye Pharma  slid 4.4%, while BeiGene  and Genscript Bio  retreated nearly 4%. Zai Lab  slipped 3%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HK0000306701.USD","LU1969619763.USD","HK0000320223.HKD","BK1500","01548","BK1191","BK1588","BK1574","BK1141","BK1606","BK1583","09688","06955","BK1576","LU0588546209.SGD","LU2328871848.SGD","BK1161","LU2488822045.USD","09966","HK0000306685.HKD","LU0307460666.USD","02186","HK0000320264.USD","06160"],"gpt_icon":0},{"id":"2526770879","title":"BRIEF-Modern Chinese Medicine Says To Allot And Issue Aggregate Of 120 Mln Subscription Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2526770879","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526770879?lang=en_us&edition=fundamental","pubTime":"2025-04-09 09:33","pubTimestamp":1744162394,"startTime":"0","endTime":"0","summary":"BRIEF-Modern Chinese Medicine Says To Allot And Issue Aggregate Of 120 Mln Subscription SharesApril 9  - Modern Chinese Medicine Group Co Ltd 1643.HK:TO ALLOT AND ISSUE AGGREGATE OF 120MLN SUBSCRIPTION SHARES AT HK$0.27 PER SHAREFurther company coverage: 1643.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QM1YP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1606","01643"],"gpt_icon":0},{"id":"2526829181","title":"Modern Chinese Medicine Group Co -  to Allot and Issue Aggregate of 120Mln Subscription Shares at HK$0.27 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2526829181","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526829181?lang=en_us&edition=fundamental","pubTime":"2025-04-09 06:13","pubTimestamp":1744150391,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM1YP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1606","01643","BK1191"],"gpt_icon":0},{"id":"2525817967","title":"BRIEF-China Traditional Chinese Medicine Says Controlling Shareholder Acquired 50.4 Million Shares Of Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2525817967","media":"Reuters","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525817967?lang=en_us&edition=fundamental","pubTime":"2025-04-08 23:39","pubTimestamp":1744126785,"startTime":"0","endTime":"0","summary":"BRIEF-China Traditional Chinese Medicine Says Controlling Shareholder Acquired 50.4 Million Shares Of CoApril 8 (Reuters) - China Traditional Chinese Medicine Holdings Co Ltd 0570.HK:CONTROLLING SHARE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM17L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","BK1515","00570","BK1191"],"gpt_icon":0},{"id":"2525183148","title":"China Traditional Chinese Medicine -  Controlling Shareholder Acquired 50.4 Mln Shares of Co at an Average Price of HK$1.86 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2525183148","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525183148?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:39","pubTimestamp":1744119576,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM17L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","00570","BK1606","BK1515"],"gpt_icon":0},{"id":"2525889522","title":"Luye Pharma Gets Macao Approval for Antidepressant","url":"https://stock-news.laohu8.com/highlight/detail?id=2525889522","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525889522?lang=en_us&edition=fundamental","pubTime":"2025-04-08 19:40","pubTimestamp":1744112444,"startTime":"0","endTime":"0","summary":"Luye Pharma  secured Macao government's approval to market toludesvenlafaxine hydrochloride extended-release tablets, according to a Monday filing with the Hong Kong bourse.The drug, branded Ruoxinlin, is indicated for major depressive disorder, the filing said.Phase 3 study results showed the drug reduces anxiety, retardation, fatigue, and anhedonia or lack of interest, promotes social functions, and improves cognition, the filing said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1606","BK1583","BK1191","02186"],"gpt_icon":0},{"id":"2525880541","title":"Consun Pharmaceutical - Young Yuk Chuen David Appointed as an Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2525880541","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525880541?lang=en_us&edition=fundamental","pubTime":"2025-04-08 12:01","pubTimestamp":1744084880,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM00H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1606","01681","BK1191"],"gpt_icon":0},{"id":"2525847045","title":"BRIEF-Luye Pharma Says Antidepressant Ruoxinlin Approved For Marketing In Macao","url":"https://stock-news.laohu8.com/highlight/detail?id=2525847045","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525847045?lang=en_us&edition=fundamental","pubTime":"2025-04-07 21:17","pubTimestamp":1744031871,"startTime":"0","endTime":"0","summary":"BRIEF-Luye Pharma Says Antidepressant Ruoxinlin Approved For Marketing In MacaoApril 7 (Reuters) - Luye Pharma Group Ltd 2186.HK:CLASS 1 INNOVATIVE ANTIDEPRESSANT RUOXINLIN APPROVED FOR MARKETING IN MACAOFurther company coverage: 2186.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL0XZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186","BK1191","BK1583","BK1606"],"gpt_icon":0},{"id":"2525019489","title":"Luye Pharma - Class 1 Innovative Antidepressant Ruoxinlin Approved for Marketing in Macao","url":"https://stock-news.laohu8.com/highlight/detail?id=2525019489","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525019489?lang=en_us&edition=fundamental","pubTime":"2025-04-07 19:01","pubTimestamp":1744023685,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL0XZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02186","BK1583","BK1606","BK1191"],"gpt_icon":0},{"id":"2525252097","title":"Calculating The Intrinsic Value Of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:874)","url":"https://stock-news.laohu8.com/highlight/detail?id=2525252097","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525252097?lang=en_us&edition=fundamental","pubTime":"2025-04-07 10:54","pubTimestamp":1743994466,"startTime":"0","endTime":"0","summary":"Key Insights Guangzhou Baiyunshan Pharmaceutical Holdings' estimated fair value is HK$17.82 based on 2 Stage Free Cash...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-874/guangzhou-baiyunshan-pharmaceutical-holdings-shares/news/calculating-the-intrinsic-value-of-guangzhou-baiyunshan-phar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["00874","BK1521","BK4211","BK1606","DCF","BK1191","BK1197","TV","FCF","BK4100","BK1515"],"gpt_icon":0},{"id":"2524253726","title":"JBM (Healthcare) Unit Buys 90% Stake in Medicine Maker","url":"https://stock-news.laohu8.com/highlight/detail?id=2524253726","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524253726?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:44","pubTimestamp":1743680662,"startTime":"0","endTime":"0","summary":"JBM   unit Arrow King completed the acquisition of a 90% equity stake in Tin Hee Tong Medicine Factory for HK$171 million, a Thursday filing with the Hong Kong bourse said.The parties had entered into the purchase agreement in February.Tin Hee Tong Medicine Factory engages mainly in the manufacture, marketing, and sales of proprietary Chinese medicine Tin Hee Tong Tin Hee Pills.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4137","MKR.USD.CC","02161","BK1606","BK1191","HCSG","MKR.USD.HKCC"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}